Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility is a research paper published in AIDS Research and Treatment (2020). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01
Grant: 1R01AI111936-01
Inflammation and HIV risk: understanding partial Tenofovir efficacy in CAPRISA004
National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01
Grant: RCA13101656388
National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01
Grant: G11 TW010555-01
National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01
Grant: TTK160517165310
NIAID NIH HHS
Grant: R01 AI111936
European & Developing Countries Clinical Trials Partnership (EDCTP)
Grant: TMA2017SF-1960
Fields of Study
Keywords
Sustainable Development Goals